All Industries

Top Genomics Companies

107 Genomics companies, sorted by total funding raised.

107

Companies

$16.1B

Combined Funding

2

Funded (Last 60d)

Seed

Top Stage

Indexed tracks 107 Genomics companies that have collectively raised $16.1B in documented funding. The most-funded genomics companies tracked include Caris Life Sciences and Ultima Genomics. 2 companies closed a new round in the last 60 days, with Seed being the most common funding stage.

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth Equity·$1.5B·Apr 2025
Ultima Genomics

Novel DNA sequencing architecture to scale the ultra low cost whole genome

Fremont, United States201–500Artificial Intelligence, Healthcare
Series E·$1.1B·Jun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
Pacific Biosciences

Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...

Menlo Park, United States501–1000Biotech, Genomics
Convertible·$900.0M·Feb 2021
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate Round·$835.0M·Jun 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate Round·$730.0M·Dec 2025
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series B·$650.0M·Oct 2025
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series D·$648.3M·Jul 2024
DNAnexus

Provides a cloud-based precision-health platform to manage, analyze, and collaborate on multi-omi...

Mountain View, United States201–500Data & Analytics, Developer Tools
Series G+·$572.0M·Mar 2022
GS Holdings (formerly Genuity Science (WuXi Nextcode Genomics – Fjord))

Genomics and data analytics company providing drug discovery and development services to global b...

Cambridge, United StatesBiotech, Healthcare
Series C·$530.0M·Nov 2018
Synthego

Provides CRISPR reagents, engineered nucleases, and GMP manufacturing to researchers and therapeu...

Redwood City, United States51–200Biotech, Genomics
Series E·$460.0M·Feb 2022
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United States201–500Biotech, Diagnostics
Series C·$435.0M·Jun 2021
Verve TherapeuticsAcquired

Develops one-time in vivo gene-editing medicines to prevent and treat atherosclerotic cardiovascu...

Boston, United States201–500Biotech, Drug Discovery
Series C·$428.5M·Oct 2024
BillionToOneIPO

The genetic testing platform detecting and measuring disease.

Menlo Park, United States201–500Biotech, Diagnostics
Venture Round·$406.0M·Mar 2026
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Corporate Round·$335.0M·Dec 2024
Ohalo Genetics

Gene editing for plant breeding to create new crop varieties.

South San Francisco, United States51–200AgriTech, Gene Editing
Series C·$317.3M·Feb 2025
NateraIPO

Natera provides DNA testing across multiple clinical areas including women’s health and oncology.

San Carlos, United States5001–10000Diagnostics, Genomics
Series E·$310.1M·Jul 2019
Neuron23

Clinical-stage biotech developing precision medicines for genetically defined Parkinson’s disease...

South San Francisco, United States11–50Biotech, Drug Discovery
Series D·$310.0M·Jun 2025
LifeMine Therapeutics

Clinical-stage biopharma mining fungal genomes to discover genetically-encoded small molecules fo...

Cambridge, United States51–200Biotech, Drug Discovery
Venture Round·$300.0M·Jan 2025
Ensoma

Genomic medicine company engineering hematopoietic stem cells in vivo to develop durable therapeu...

United StatesBiotech, Genomics
Venture Round·$258.0M·Sep 2025
Sophia GeneticsIPO

AI-driven platform that analyzes genomic, radiomic, and multimodal healthcare data for hospitals,...

Lausanne, Switzerland201–500Artificial Intelligence, Data & Analytics
Series F·$245.8M·Oct 2020
Personal Genome DiagnosticsAcquired

Innovative genomic technologies to solve fundamental challenges in oncology

Baltimore, United States51–200Biotech, Cancer Diagnostics
Series C·$244.2M·Feb 2021
Ray Therapeutics

Developing novel optogenetic gene therapies for patients with blinding diseases.

Berkeley, United States11–50Biotech, Genomics
Series B·$241.0M·Apr 2026
Scipher Medicine

Precision immunology company using AI and clinico-genomic data to match autoimmune patients with ...

Boston, United States51–200Artificial Intelligence, Drug Discovery
Series D·$197.8M·Jul 2024
SpliceBio

SpliceBio is a biotechnology company exploiting Protein Splicing to develop next generation gene ...

Barcelona, Spain11–50Biotech, Drug Discovery
Series B·$192.0M·Jun 2025

Frequently Asked Questions

How many Genomics companies are tracked on Indexed?

Indexed tracks 107 Genomics companies, sorted by total funding raised.

How much funding have Genomics companies raised in total?

The Genomics companies tracked by Indexed have collectively raised $16.1B in documented funding.

What are the top-funded Genomics companies?

The most-funded Genomics companies tracked include Caris Life Sciences, Ultima Genomics, Alnylam Pharmaceuticals.

Who are the top investors in Genomics?

Leading investors active in Genomics include Illumina Ventures, Civilization Ventures, ARK Invest.

Explore More

Other Industries